Dundalk – Talk Bio

Actionable Insights Powered by AI

WuXi Biologics Divests Irish Vaccine Facility to Merck for $500 Million Amid Strategic Shift

WuXi Biologics, Merck, vaccine manufacturing facility, Dundalk, Ireland, asset sale, strategic shift, regulatory changes, Biosecure Act